Etoposide, CAS No. : 33419-42-0, etoposide is mainly used in the treatment of small cell lung cancer, malignant lymphoma, malignant germ cell tumors, leukemia, neuroblastoma, leiomyosarcoma and ovarian cancer, non-small cell lung cancer, gastric cancer and esophageal cancer have certain curative effect. It's now a broad-spectrum cancer drug, and the market is huge. We have researched and designed a new technological route, which has been successfully carried out in industrial production. New technology of side chain without hydrogenation, high yield, have a great lower production cost than the current process, the finished API quality is higher than the Chinese pharmacopoeia, the United States pharmacopoeia, and the European pharmacopoeia, product purity up to 100% (HPLC), main product of HaiKang company.